(AP) -- A Minnesota family is trying to force a New Jersey drug company to give their son an experimental drug for a fatal form of muscular dystrophy, saying he'll die without it.
Related stories:
Judge: Company must give experimental drug to teen
(AP) -- A federal judge on Wednesday ordered a research company to supply an experimental drug to a 16-year-old Minnesota boy who is terminally ill with a rare form of muscular dystrophy. The decision offers no immediate relief to Jacob Gunvalson. Due to federal regulations, the teen cannot begin taking the drug immediately.
Cocaine-induced brain plasticity may protect the addicted brain
A new study has unraveled some of the mysteries of the cocaine-addicted brain and may pave the way for the design of more effective treatments for drug addiction. The research, published by Cell Press in the August 28 issue of the journal
Neuron, identifies specific brain mechanisms that underlie addiction-related structural changes in the brain and provides surprising insight into how these changes may actually defend the brain during excessive drug use.
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. Transcripts for several different ABC-transporters, e.g. MDR-1 (P-gp) and MRPs, were detected in endothelial cells, obtained from brain, aortic artery, pulmonary artery, dermal microvessels and umbilical veins.
Broadcom co-founder apologizes after plea deal
(AP) -- Broadcom Corp. co-founder Henry Samueli has apologized for lying to the Securities and Exchange Commission during its probe of stock options backdating at the chip maker.
New approach needed to tackle child abuse and neglect
Leading child advocates have called for a new approach to tackling child abuse and neglect amid rising rates of abuse notifications and children being brought into State care. The arguments for a new approach are set out in the latest edition of the
Australian and New Zealand Journal of Public Health.
Compounds have potential for diagnosis, treatment of Alzheimer's disease
New research suggests that a select group of compounds that interact with a protein in the brain might be used in the early diagnosis and treatment of Alzheimer's disease and other dementia disorders.
Biodegradable polymers show promise for improving treatment of acute inflammatory diseases
A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body.
Education needed to decrease teens' misconception about emergency contraception
Targeted health education may help urban, minority adolescent women better understand how the emergency contraception pill works and eliminate some misconceptions about side effects, confidentiality and accessibility, according to a study by The Children's Hospital of Philadelphia.